Close
Novotech
Jabsco PureFlo 21 Single Use

News

Roche NimbleGen Introduces Novel NGS Target Enrichment Solution for Methylation Assessment

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced the launch of the SeqCap Epi Target Enrichment System for DNA methylation assessment at single-base resolution. This system includes both a fixed content epigenome-wide design and a full range of custom target...

AMSilk Advances Silicone Breast Implant Coating

New research paper about the coating of silicone implants with recombinant spider silk. AMSilk has completed preclinical testing of its proprietary silicone implant coating made from spider silk. AMSilk's coating consists of a thin layer of spider silk proteins...

PharmaCell to Purchase Cell Therapy Production Facility from TiGenix

PharmaCell B.V. a leading Contract Manufacturing Organization for Cellular Therapies and Regenerative Medicine in Europe, announced today that it has entered into an agreement with TiGenix N.V. to purchase its state-of-the-art cell therapy production facility at the Chemelot site...

Breakthrough announced in treatment of patient with rare type of leukemia

A team of scientists from the University of Leicester has demonstrated a novel treatment for Hairy Cell Leukaemia (HCL), a rare type of blood cancer, using a drug administered to combat skin cancer. The research,...

Clever chemistry and a new class of antibiotics

As concerns about bacterial resistance to antibiotics grow, researchers are racing to find new kinds of drugs to replace ones that are no longer effective. One promising new class of molecules called acyldepsipeptides - ADEPs - kills bacteria in...

Scientists demonstrate method to find new therapies

Scientists at The Scripps Research Institute (TSRI) have demonstrated the power of a new drug discovery technique, which allows them to find - relatively quickly and cheaply - antibodies that have a desired effect on cells. The TSRI scientists...

World’s tiniest drug cabinets could be attached to cancerous cells for long term treatment

Reservoirs of pharmaceuticals could be manufactured to bind specifically to infected tissue such as cancer cells for slow, concentrated delivery of drug treatments, according to new research published in ACS Macro Letters. The findings, from the University of Copenhagen...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »